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ABSTRACT
Aim: Biologically uncommon D-b-aspartic acid (D-b-Asp)
accumulates in the body with age and is involved in the
ageing process. In the present study, the localisation of D-
b-Asp-containing proteins was investigated in surgical
specimens with climatic droplet keratopathy (CDK), one of
the ocular changes related to the ageing process.
Methods: Immunohistochemical localisation of D-b-Asp-
containing proteins using polyclonal antibodies raised
against D-b-Asp-containing peptides was examined in
three corneas with CDK, three corneas with interstitial
keratitis, six corneas with bullous keratopathy, and three
corneas without any corneal diseases.
Results: Strong immunoreactivity to D-b-Asp-containing
peptide was detected in all the surgical specimens with
CDK. In contrast, no immunoreactivities to D-b-Asp-
containing peptides were detected in the surgical
specimens with bullous keratopathy, interstitial keratitis,
or no corneal diseases.
Conclusions: CDK was regarded as aggregations of D-b-
Asp-containing proteins. The formation of D-amino acids in
protein causes the different side chain orientations and b-
linkage of Asp residues elongates the main chain of
proteins. Therefore, D-b-Asp formation will result in a
partial unfolding of proteins leading to the aggregation of
proteins seen in CDK.
Climatic droplet keratopathy (CDK), also known as
spheroid degeneratation of the cornea, is common
and is one of the leading causes of blindness
especially elderly people living in equatorial and
polar regions.1 For example, CDK accounts for 57%
of all the cases of blindness in the Dahlak Islands
located in the Red Sea.2 Epidemiological studies have
confirmed that ultraviolet irradiation and age are
closely related to the development of CDK.1
Histological studies have shown the accumulation
of amorphous materials especially in the superficial
layer of the cornea with CDK. However, the nature
of the amorphous materials and the pathogenesis of
CDK are still unclear.
One of the molecular mechanisms of ageing
process is the formation of D-amino acids.
Although protein of all living organisms are
composed exclusively of L-amino acids, biologically
uncommon D-amino acids, that is enantiomer of L-
amino acid, has been recognised as a molecular
basis of diseases related to ultraviolet irradiation
and ageing process.3 D-aspartic acids (D-Asp) were
found in the lenses,3–6 teeth,7 8 bones,9 brains,10
skin,11 aortas,12 erythrocytes,13 lungs,14 and liga-
ments of elderly donors.8 The presence of D-Asp in
aged tissues of the living body is considered to be a
result of racemisation of L-Asp in proteins in such
metabolically inert tissues during one’s life time. In
addition, D-aspartic acid in living organisms is
considered to be not only an index of ultraviolet
irradiation but also a useful marker of the ageing
process.
This study was undertaken to reveal the
contribution of D-Asp in the pathogenesis of
CDK. To this end, the immunohistochemical
localisation of D-b-Asp-containing proteins was
investigated in surgical specimens with CDK.
MATERIALS AND METHODS
Surgical specimens of cornea with or without
climatic droplet keratopathy
Informed consent was obtained from all the patients
undergoing corneal surgery in the present study.
Reviewing all the corneal specimens submitted to
the department of pathology, University of Tokyo
from April 1994 to January 2008, we have found
three corneas with CDK from three patients (two
male and one female, 62.0 (SD 4.0) years old). One
male patient had no past history of keratitis,
indicating that the patient had primary CDK. The
others had past histories of interstitial keratitis with
congenital syphilis, indicating that they had second-
ary CDK. Appropriate slit-lamp images of the
corneas of the patients with CDK were not obtained.
In addition, six corneas with bullous keratopathy
from six patients (four male and two female, 58.3
(8.4) years old), three corneas with interstitial
keratitis (two male and one female, 59.7 (9.0) years
old) and three corneas without any corneal diseases
(two male and one female, 66.0 (6.2) years old) were
obtained. Haematoxylin–eosin staining and immu-
nohistochemistry described as follows were per-
formed on all the surgical specimens.
Antibody against D-b-aspartic acid-containing
peptides
The preparation and characterisation of the poly-
clonal antibody against D-b-Asp-containing pep-
tides have been previously described.4 11 The
polyclonal antibody against the peptide, Gly-Leu-
D-b-Asp-Ala-Thr-Gly-Leu-D-b-Asp-Ala-Thr-Gly-
Leu-D-b-Asp-Ala-Thr (antipeptide 3R antibody),
which corresponds to three repeats of positions
149–153 of human a-A-crystallin, was prepared
and purified as described by Fujii et al. The
antibody clearly distinguished the configuration
of the Asp-residue, that is, it reacted strongly with
the D-b-Asp-containing peptides but did not react
with the L-a-Asp, L-b-Asp, or D-a-Asp-containing
peptides.4 11
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Immunohistochemistry
Immunohistochemical localisation of D-b-Asp-containing pep-
tides was investigated using the antibody mentioned ear-
lier.11 15 16 Briefly, the surgical specimens were fixed with 4%
paraformaldehyde (Sigma, St Louis, Missouri) in 0.1 M phos-
phate buffer (pH 7.4) for 24 h. After embedding in paraffin, 4-
mm-thick sections of samples were prepared. Following depar-
affinisation, the sections were treated with a polyclonal
antibody to D-b-Asp-containing peptides at a dilution of 1:500
dissolved with phosphate-buffered saline (PBS) containing 1%
normal bovine serum albumin and kept at 4uC overnight. After
washing the section with PBS, the samples were treated with
the reaction solution containing a secondary antibody labelled
with horseradish peroxidase (Histofine Max-PO kit: NICHIREI,
Tokyo) and kept for 30 min at room temperature. The sections
were then incubated with diaminobenzidine (Sigma) in PBS.
Finally, the sections were counterstained with haematoxylin. As
a negative control, the primary antibody was replaced with
normal rabbit serum IgG (1.0 mg/ml) diluted in PBS containing
1% bovine serum albumin (Sigma).
To evaluate the specificity of the binding of the primary
antibody to D-b-Asp-containing peptides, the sections were
incubated with the mixture of the primary antibody and 10 mg/
ml of peptide 3R instead of using the primary antibody alone.
Then, the samples were treated with the secondary antibody
followed by diaminobenzidine in PBS.
The results of the immunohistochemistry were checked and
graded in double-blinded manner.
RESULT
Examples of haematoxylin–eosin staining and immunohisto-
chemistry in a cornea with CDK are shown in fig 1. In
specimens of CDK, numerous eosinophilic amorphous materials
were observed in the superficial layer of the corneal stroma
(fig 1A). Strong immunoreactivity to D-b-Asp was detected in
the amorphous materials in the superficial layer of the cornel
stroma (fig 1B). Incubation with D-b-Asp-containing peptides
(peptide 3R) in the reaction mixture almost completely blocked
the immunoreactivity to D-b-Asp (fig 1C).
In corneal specimens with bullous keratopathy (fig 1D),
interstitial keratitis (fig 1E) or no corneal diseases (fig 1F),
immunoreactivity to D-b-Asp was not detected.
DISCUSSION
This study was undertaken to reveal the nature of amorphous
materials seen in CDK in relation to D-amino acid. D-b-Asp-
containing proteins exist in the amorphous materials in CDK. A
previous study has shown that the amorphous materials in
CDK are aggregations of proteins that contain advanced
glycation end-products (AGEs) including Ne-(carboxy)methyl-
L-lysine, pyrraline, pentosidine and imidazolone.16 Taken
together, the formation and accumulation of AGEs and D-b-
Asp-containing proteins underlie the pathogenesis of CDK.
The localisation of AGEs and D-amino acids containing
proteins in tissues seems to be common. First, ultraviolet
irradiation accelerates the formation of AGEs and D-amino
acids. Second, AGEs and D-amino-acid-containing proteins
accumulate with age and are involved in the pathogenesis of
age-related disorders. Third, the formation of AGEs and D-
amino acids induces aggregation of and major structural
changes in the proteins. Fourth, the first step of AGE formation,
the Maillard reaction, is known to accelerate the formation of D-
amino acids.17 In addition, AGEs and D-amino acids are known
to colocalise in various pathological conditions including
cataract,3–6drusens6 18 and actinic keratosis.11
The role of D-amino acids in the pathogenesis of age-related
diseases has been extensively analysed in the lens.4 5 19–21
Cataract formation is one of the most prominent age-related
Figure 1 Immunohistochemical localisation of D-b-aspartic acid-containing protein. Eosinophilic and amorphous materials are observed in the
superficial layer of the corneal stroma (A) with CDK. The materials were positive for D-b-Asp (B). Incubation with D-b-Asp-containing peptide in the
reaction mixture almost completely blocked the immunoreaction (C). No immunoreaction was observed in cornea with bullous keratopathy (D),
interstitial keratitis (E) or corneas without any corneal diseases (F). In all figures, bar = 100 mm.
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changes in the lens. Various post-translational modifications
including AGE formation, racemisation of aspartic residues and
the formation of disulfide bridges occur in lens proteins.22 These
molecular modifications result in structural changes in the lens
proteins and in the formation of high-molecular-weight protein
aggregates. Among them, racemisation and isomerisation of
aspartyl residues and their resultant D-b-Asp formation may
affect the aggregation of protein because the side chain of
orientation of D-Asp residues turns upside down, and the main
chain of the peptide bond contain b-linkage is elongated.4 5 20
With the antibody, the accumulation of D-b-Asp-containing
proteins in skin and various parts of eyes including the lens,
sclera, ciliary epithelium, internal limiting membrane, lamina
cribrosa and drusens has been reported.6 In the present study,
we have shown the accumulation of D-b-Asp-containing
proteins in CDK but not in corneas with bullous keratopathy,
interstitial keratitis or no corneal diseases. However, D-b-Asp-
containing proteins may spread to a wider area because the
antibody to peptide 3R does not recognise all the D-b-Asp-
containing peptides in tissue. For this reason, HPLC and
spectrometry as well as immunohistochemistry are needed to
investigate the role of D-amino acids in ageing processes.
Accumulation of D-amino acids has been regarded as a cause
of the ageing process. This indicates that the inversion of L- to D-
amino acids or the breakdown of D-amino-acid-containing
proteins will have a therapeutic effect on CDK. The ubiquitin
and proteasome systems may serve to break down intracellular
D-amino-acid-containing proteins.23 In addition, Kinouchi et al
have reported that D-aspartyl end peptidase, which cleaves D-
Asp-containing peptide, is detected in various tissues including
liver, kidney, spleen and lung.24 These systems serve as an
endogenous protective mechanism against the accumulation of
D-amino-acid-containing proteins in tissue. The regulation of
these systems will be a clue to prevention and treatment of age-
related disorders including CDK.
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